Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Er-cheng Chen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 21, 2012
[One case of lymph node interdigitating dendritic cell sarcoma]Er-cheng Chen, Jin-bo Ma, Yi-peng Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 11, 2005
[Prognostic factors and treatment of 74 patients with dermatofibro-sarcoma protuberans]Meng-zhong Liu, Xiu-shen Wang, Ling Cai, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2012
Moderately hypofractionated conformal radiation treatment of thoracic esophageal carcinomaJin-Bo Ma, Lin Wei, Er-Cheng Chen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinomaJin-Bo Ma, Er-Cheng Chen, Yi-Peng Song, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Efficacy and safety of late-course hypofractionated radiation therapy for muscle-invasive bladder carcinoma after bladder-conserving surgeryYi-Peng Song, Jin-Bo Ma, Lin Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Local failure-related factors of esophageal carcinoma after concurrent chemoradiotherapy]Er-Cheng Chen, Meng-Zhong Liu, Yong-Hong Hu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|June 11, 2005
[Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy]Er-Cheng Chen, Meng-Zhong Liu, Yong-Hong Hu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|May 14, 2005
[Phase I study of CM-Na combined with concurrent radiochemotherapy for advanced esophageal carcinoma]Ling Cai, Meng-Zhong Liu, Mo-Fa Gu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 21, 2012
[One case of lymph node interdigitating dendritic cell sarcoma]Er-cheng Chen, Jin-bo Ma, Yi-peng Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 11, 2005
[Prognostic factors and treatment of 74 patients with dermatofibro-sarcoma protuberans]Meng-zhong Liu, Xiu-shen Wang, Ling Cai, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2012
Moderately hypofractionated conformal radiation treatment of thoracic esophageal carcinomaJin-Bo Ma, Lin Wei, Er-Cheng Chen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinomaJin-Bo Ma, Er-Cheng Chen, Yi-Peng Song, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Efficacy and safety of late-course hypofractionated radiation therapy for muscle-invasive bladder carcinoma after bladder-conserving surgeryYi-Peng Song, Jin-Bo Ma, Lin Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 12, 2005
[Local failure-related factors of esophageal carcinoma after concurrent chemoradiotherapy]Er-Cheng Chen, Meng-Zhong Liu, Yong-Hong Hu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|June 11, 2005
[Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy]Er-Cheng Chen, Meng-Zhong Liu, Yong-Hong Hu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|May 14, 2005
[Phase I study of CM-Na combined with concurrent radiochemotherapy for advanced esophageal carcinoma]Ling Cai, Meng-Zhong Liu, Mo-Fa Gu, et al.
Pageof 1